These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 11827003)

  • 21. Corneal staining after treatment with topical tetracycline.
    Lapid-Gortzak R; Nieuwendaal CP; Slomovic AR; Spanjaard L
    Cornea; 2006 Sep; 25(8):969-70. PubMed ID: 17102677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and characterization of mucoadhesive nanosuspension of ciprofloxacin.
    Jain V; Kare P; Jain D; Singh R
    Acta Pol Pharm; 2011; 68(2):273-8. PubMed ID: 21485301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gels and liposomes in optimized ocular drug delivery: studies on ciprofloxacin formulations.
    Budai L; Hajdú M; Budai M; Gróf P; Béni S; Noszál B; Klebovich I; Antal I
    Int J Pharm; 2007 Oct; 343(1-2):34-40. PubMed ID: 17537601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An in vivo study comparing the ocular absorption of levofloxacin and ciprofloxacin prior to phacoemulsification.
    Bucci FA
    Am J Ophthalmol; 2004 Feb; 137(2):308-12. PubMed ID: 14962422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of topical fixed-combination fortified vancomycin-amikacin (VA solution) to conventional separate therapy in the treatment of bacterial corneal ulcer.
    Chiang CC; Lin JM; Chen WL; Chiu YT; Tsai YY
    Eye (Lond); 2009 Feb; 23(2):294-8. PubMed ID: 18188174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of topically applied ciprofloxacin in rabbit tears.
    Green LC; Callegan MC; Engel LS; Shimomura Y; Jasheway DW; O'Callaghan RJ; Hill JM
    Jpn J Ophthalmol; 1996; 40(1):123-6. PubMed ID: 8739510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scanning electron microscopy and energy-dispersive X-ray microanalysis studies of early dental calculus on resin plates exposed to human oral cavities.
    Kodaka T; Ohohara Y; Debari K
    Scanning Microsc; 1992 Jun; 6(2):475-85; discussion 485-6. PubMed ID: 1462133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
    Caballero AR; Marquart ME; O'Callaghan RJ; Thibodeaux BA; Johnston KH; Dajcs JJ
    Curr Eye Res; 2006 Jan; 31(1):23-9. PubMed ID: 16421016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of topical fluoroquinolones on the pathogenesis of diffuse lamellar keratitis in experimental in vivo studies.
    Mah FS; Romanowski EG; Dhaliwal DK; Yates KA; Gordon YJ
    J Cataract Refract Surg; 2006 Feb; 32(2):264-8. PubMed ID: 16565003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease.
    Adi H; Young PM; Chan HK; Agus H; Traini D
    Eur J Pharm Sci; 2010 Jun; 40(3):239-47. PubMed ID: 20371286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ciprofloxacin-ampicillin sulbactam incompatibility.
    Melonakos TK
    Ann Pharmacother; 1996 Jan; 30(1):87. PubMed ID: 8773177
    [No Abstract]   [Full Text] [Related]  

  • 32. Everything in a compatibility study is important.
    Trissel LA
    Am J Health Syst Pharm; 1996 Dec; 53(24):2990. PubMed ID: 8974165
    [No Abstract]   [Full Text] [Related]  

  • 33. Compatibility of ciprofloxacin lactate with sodium bicarbonate during simulated Y-site administration.
    Gilbert DL; Trissel LA; Martinez JF
    Am J Health Syst Pharm; 1997 May; 54(10):1193-5. PubMed ID: 9161629
    [No Abstract]   [Full Text] [Related]  

  • 34. Zwitterions and pH-dependent solubility.
    Williams DA
    Am J Health Syst Pharm; 1996 Jul; 53(14):1732. PubMed ID: 8827246
    [No Abstract]   [Full Text] [Related]  

  • 35. The ultrastructure of tomatine adjuvant.
    Yang YW; Sheikh NA; Morrow WJ
    Biomaterials; 2002 Dec; 23(23):4677-86. PubMed ID: 12322989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of container structures and content solutions on dispensing time of ophthalmic solutions.
    Yoshikawa K; Yamada H
    Clin Ophthalmol; 2010 May; 4():481-6. PubMed ID: 20535225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Microscopic study of spiral-like growth of crystals].
    BRANDSTATTER M
    Mikroskopie; 1955 Jul; 10(1-2):19-24. PubMed ID: 13279560
    [No Abstract]   [Full Text] [Related]  

  • 38. Tables for the microscopic identification of N.F. VII crystalline substances.
    KEENAN GL; EISENBERG WV
    J Am Pharm Assoc Am Pharm Assoc; 1946 Mar; 35():94-6. PubMed ID: 21018240
    [No Abstract]   [Full Text] [Related]  

  • 39. Derivation of the equation of isostatic line of compression and splitting force in a bottle-shaped strut.
    Yuan A; Aikebaier M; Qian S; Dai H
    MethodsX; 2018; 5():865-870. PubMed ID: 30151346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The new genetics: which genie out of which bottle?
    BMJ; 2000 Nov; 321(7269):F. PubMed ID: 11061758
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.